What compounds in Illawarra plum provide health benefits?

Illawarra plum contains polyphenolic compounds responsible for its anti-cancer activity. These polyphenols demonstrate selective cytotoxicity against colon cancer cells with an IC50 of 1318 μg/ml in laboratory studies.

How effective is Illawarra plum against cancer?

Laboratory studies show Illawarra plum extracts inhibit HT29 colon cancer cell growth in a dose-dependent manner while sparing healthy cells. However, evidence is limited to test tube studies with no human clinical trials conducted.

Is Illawarra plum safe to consume as a supplement?

Safety data for Illawarra plum supplements is lacking due to limited research. While traditionally consumed as food, concentrated extracts may have different safety profiles and should be used with caution.

What is the recommended dosage for Illawarra plum?

No standardized dosage exists for Illawarra plum supplements due to lack of human studies. Laboratory research used extract concentrations around 1318 μg/ml, but this cannot be directly translated to human dosing recommendations.

Can Illawarra plum interact with cancer medications?

No documented interactions exist, but theoretical concerns arise given the anti-cancer activity observed in laboratory studies. Patients undergoing cancer treatment should consult healthcare providers before using Illawarra plum supplements.

What is the difference between Illawarra plum extract and whole fruit supplementation?

Illawarra plum extracts concentrate the bioactive polyphenolic compounds, achieving higher antioxidant potency per dose compared to whole fruit preparations. Research demonstrating anti-cancer cell activity used polyphenolic extracts rather than whole fruit, suggesting extraction methods may enhance therapeutic compound bioavailability. Whole fruit provides additional fiber and minerals but requires larger quantities to match the polyphenol concentration found in standardized extracts.

Is Illawarra plum supplementation safe during pregnancy and breastfeeding?

Limited safety data exists for Illawarra plum supplementation in pregnant and breastfeeding women, making it prudent to avoid supplemental forms during these periods. While the fruit is traditionally consumed in its native region, concentrated extracts have not been evaluated for fetal or infant safety. Consult with a healthcare provider before using any Illawarra plum supplement if pregnant, planning pregnancy, or breastfeeding.

How strong is the clinical evidence supporting Illawarra plum's health benefits in humans?

Current evidence for Illawarra plum is limited to in vitro (laboratory cell) studies, with no published human clinical trials confirming its health effects. While polyphenolic extracts showed dose-dependent inhibition of colon cancer cells in test tubes, this does not directly translate to efficacy in human subjects. More research including animal studies and human clinical trials would be needed to establish reliable health claims for supplementation.

Podocarpus elatus (Illawarra Plum)

Illawarra plum (Podocarpus elatus) is an Australian native fruit containing polyphenolic compounds that demonstrate selective anti-cancer activity. The fruit's extracts specifically target colon cancer cell proliferation while sparing healthy cells through antioxidant mechanisms.

Category: Herb Evidence: 2/10 Tier: Emerging

Podocarpus elatus (Illawarra Plum) — Hermetica Encyclopedia

Origin & History

Podocarpus elatus, or Illawarra Plum, is a wild-harvested bush fruit native to the eastern coast of Australia. The fruit is processed to create bioactive extracts, with 50% ethanol being a highly effective and food-safe solvent for concentrating its rich phenolic and anthocyanin compounds. These extracts are typically produced as standardized, lyophilized powders for use in research and supplements.

Historical & Cultural Context

The available research dossier does not document any historical or traditional medicinal uses for Illawarra Plum. It is primarily identified as a native Australian bush fruit, with modern scientific interest focused on its high concentration of bioactive compounds.

Health Benefits

["\u2022 May inhibit colon cancer cell proliferation (evidence quality: in vitro). A polyphenolic extract inhibited HT29 colon cancer cell growth in a dose-dependent manner (IC50: 1318 \u03bcg/ml at 48h) without significantly affecting non-cancerous cells (PMID: 23069328).", "\u2022 Exhibits potent antioxidant activity (evidence quality: in vitro). Extracts demonstrated strong free radical scavenging capabilities, with a 50% ethanol extract measuring 153.22 \u00b1 39.67 mg Trolox Equivalents (TE) per gram.", "\u2022 May inhibit telomerase in cancer cells (evidence quality: in vitro). The extract was shown to inhibit telomerase activity in HT29 colon cancer cells, a mechanism associated with controlling cancer cell immortality (PMID: 23069328).", "\u2022 May increase histone deacetylase (HDAC) activity (evidence quality: in vitro). In lab studies on HT29 colon cancer cells, the extract increased HDAC activity, which is involved in gene expression regulation and tumor suppression (PMID: 23069328).", "\u2022 Provides a concentrated source of polyphenols (evidence quality: chemical analysis). Illawarra Plum contains significantly higher levels of bioactive compounds than common berries, with 2.4-fold more phenolics and 1.7-fold more anthocyanins than blueberries."]

How It Works

Illawarra plum's polyphenolic compounds exert selective cytotoxic effects on cancer cells through oxidative stress modulation and cell cycle arrest. The extract demonstrates dose-dependent inhibition of HT29 colon cancer cells with an IC50 of 1318 μg/ml at 48 hours. The mechanism involves targeting cancer cell-specific metabolic vulnerabilities while preserving normal cellular function through antioxidant pathways.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses on Podocarpus elatus were identified in the available research. All current evidence is derived from in vitro (cell-based) studies, such as one key study on human colon cancer cells (PMID: 23069328).

Clinical Summary

Current evidence for Illawarra plum is limited to in vitro studies examining anti-cancer properties. Laboratory research shows polyphenolic extracts selectively inhibit colon cancer cell proliferation in HT29 cell lines without affecting non-cancerous cells. The research demonstrates dose-dependent effects with quantified IC50 values, but human clinical trials are lacking. Evidence quality remains preliminary, requiring advancement to animal studies and human trials to establish therapeutic relevance.

Nutritional Profile

{"macronutrients": {"carbohydrates": "Approximately 10-15g per 100g", "fiber": "Around 2-3g per 100g", "protein": "Low, approximately 1g per 100g", "fats": "Negligible"}, "micronutrients": {"vitamin_C": "Moderate, approximately 10-15mg per 100g", "vitamin_E": "Low, around 0.5mg per 100g", "potassium": "Moderate, approximately 150mg per 100g", "calcium": "Low, around 10mg per 100g", "iron": "Low, approximately 0.2mg per 100g"}, "bioactive_compounds": {"polyphenols": "High, with specific compounds like proanthocyanidins contributing to antioxidant activity", "anthocyanins": "Present, contributing to the fruit's color and antioxidant properties"}, "bioavailability_notes": "The bioavailability of polyphenols and anthocyanins can be affected by factors such as food matrix and individual digestive variations. Cooking or processing may alter the concentrations of some nutrients."}

Preparation & Dosage

No clinically studied dosages for Podocarpus elatus exist due to a complete lack of human trials. In vitro studies used polyphenolic extract concentrations of 1318–4001 μg/ml, which are not equivalent to a human oral dose. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Quercetin, Green Tea Extract (EGCG), Ellagic Acid

Safety & Interactions

Safety data for Illawarra plum supplements is extremely limited due to lack of human studies. As a wild-harvested food, potential variability in active compound concentrations may affect safety profiles. No known drug interactions have been documented, though theoretical interactions with chemotherapy agents warrant caution given the anti-cancer activity observed in vitro. Pregnancy and breastfeeding safety has not been established, and use should be avoided during these periods.